Literature DB >> 21978346

Changes in cystic fibrosis mortality in Australia, 1979-2005.

David W Reid1, C Leigh Blizzard, Dace M Shugg, Ceri Flowers, Catherine Cash, Hugh M Greville.   

Abstract

OBJECTIVE: To assess mortality trends among people with cystic fibrosis (CF) in Australia. DESIGN AND
SETTING: We augmented Australian summary data for deaths from CF registered during 1979-2005 with information from Australian transplant centres on lung transplantation among CF patients for 1989-2005 to allow us to follow trends in all "mortality events" (death or lung transplantation). MAIN OUTCOME MEASURE: Age at death or lung transplantation.
RESULTS: Between 1979 and 2005, the mean age at death increased from 12.2 years to 27.9 years for males and from 14.8 years to 25.3 years for females. Overall, female deaths in childhood (0-14 years) occurred at an age-standardised rate of 0.40 per 100,000 (95% CI, 0.34-0.45) during 1979-2005, which exceeded the corresponding rate for males of 0.24 (95% CI, 0.20-0.28) per 100,000. Among 0-14-year-old boys, event rates declined markedly after 1989, but they declined later and more gradually for girls, with the result that the age-standardised rate for girls was 2.38 times that of boys during 1989-2005 (95% CI, 1.69-3.36).
CONCLUSIONS: The pattern of CF mortality in Australia has changed substantially. Mortality rates continue to be higher for girls than for boys, but death in childhood has become uncommon. Survival has increased since 1979, but females continue to have reduced length of life.

Entities:  

Mesh:

Year:  2011        PMID: 21978346     DOI: 10.5694/mja10.11229

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  12 in total

Review 1.  Lung transplant referral for individuals with cystic fibrosis: Cystic Fibrosis Foundation consensus guidelines.

Authors:  Kathleen J Ramos; Patrick J Smith; Edward F McKone; Joseph M Pilewski; Amy Lucy; Sarah E Hempstead; Erin Tallarico; Albert Faro; Daniel B Rosenbluth; Alice L Gray; Jordan M Dunitz
Journal:  J Cyst Fibros       Date:  2019-03-27       Impact factor: 5.482

Review 2.  Lung transplantation for cystic fibrosis: results, indications, complications, and controversies.

Authors:  Joseph P Lynch; David M Sayah; John A Belperio; S Sam Weigt
Journal:  Semin Respir Crit Care Med       Date:  2015-03-31       Impact factor: 3.119

3.  Correspondence between lung function and symptom measures from the Cystic Fibrosis Respiratory Symptom Diary-Chronic Respiratory Infection Symptom Score (CFRSD-CRISS).

Authors:  Laura S Gold; Donald L Patrick; Ryan N Hansen; Christopher H Goss; Larry Kessler
Journal:  J Cyst Fibros       Date:  2019-05-22       Impact factor: 5.482

Review 4.  The Exocrine Pancreas in Cystic Fibrosis in the Era of CFTR Modulation: A Mini Review.

Authors:  Isabelle R McKay; Chee Y Ooi
Journal:  Front Pediatr       Date:  2022-06-27       Impact factor: 3.569

Review 5.  Nontuberculous mycobacteria: the changing epidemiology and treatment challenges in cystic fibrosis.

Authors:  Janice M Leung; Kenneth N Olivier
Journal:  Curr Opin Pulm Med       Date:  2013-11       Impact factor: 3.155

6.  Cost-of-illness analysis and regression modeling in cystic fibrosis: a retrospective prevalence-based study.

Authors:  Tomáš Mlčoch; Jiří Klimeš; Libor Fila; Věra Vávrová; Veronika Skalická; Marek Turnovec; Veronika Krulišová; Jitka Jirčíková; Dana Zemková; Klára Vilimovská Dědečková; Alena Bílková; Vladimíra Frühaufová; Lukáš Homola; Zuzana Friedmannová; Radovan Drnek; Pavel Dřevínek; Tomáš Doležal; Milan Macek
Journal:  Eur J Health Econ       Date:  2016-01-07

7.  Clinical consequences of human evolution shaped by cultural trends.

Authors:  Neil S Greenspan
Journal:  Evol Med Public Health       Date:  2013-01-03

8.  Genetic influences on cystic fibrosis lung disease severity.

Authors:  Colleen A Weiler; Mitchell L Drumm
Journal:  Front Pharmacol       Date:  2013-04-23       Impact factor: 5.810

9.  Showing Value in Newborn Screening: Challenges in Quantifying the Effectiveness and Cost-Effectiveness of Early Detection of Phenylketonuria and Cystic Fibrosis.

Authors:  Scott D Grosse
Journal:  Healthcare (Basel)       Date:  2015-11-11

10.  Early diagnosis from newborn screening maximises survival in severe cystic fibrosis.

Authors:  Gloria Tridello; Carlo Castellani; Ilaria Meneghelli; Anna Tamanini; Baroukh M Assael
Journal:  ERJ Open Res       Date:  2018-04-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.